Table of contents

Extended reports

• Differential expression of syndecans and glypicans in chronically inflamed synovium (1 June, 2007)

  A M Patterson, A Cartwright, G David, O Fitzgerald, B Bresnihan, B A Ashton, J Middleton
• Selective p38MAPK isoform expression and activation in antineutrophil cytoplasmatic antibody-associated crescentic glomerulonephritis: role of p38MAPKα (17 August, 2007)

  K Polzer, A Soleiman, W Baum, R Axmann, J Distler, K Redlich, A Kilian, G Krönke, G Schett, J Zwerina
• Uric acid lowering therapy: prescribing patterns in a large cohort of older adults (29 August, 2007)

  D H Solomon, J Avorn, R Levin, M A Brookhart
• Increased exposure to statins in patients developing chronic muscle diseases: a 2-year retrospective study (3 September, 2007)

  L Sailler, C Pereira, A Bagheri, M Lapeyre-Mestre, J L Montastruc, P Arlet, E Arlet-Suau, E Uro-Coste, H Roussel, D Adoue, B Fournie, L Zabraniecki, M Laroche, P Cintas
• Infliximab inhibits bone resorption by circulating osteoclast precursor cells in patients with rheumatoid arthritis and ankylosing spondylitis (24 August, 2007)

  M Gengenbacher, H-J Sebald, P M Villiger, W Hofstetter, M Seitz
• A double-blind placebo controlled trial of etanercept in patients with giant cell arteritis and corticosteroid side effects (17 December, 2007) Free

  V M Martínez-Taboada, V Rodríguez-Valverde, L Carreño, J López-Longo, M Figueroa, J Belzunegui, E M Mola, G Bonilla
• Poly(ADP-ribose) polymerase inhibition reduces tumor necrosis factor-induced inflammatory response in rheumatoid synovial fibroblasts (21 September, 2007)

  S García, A Bodaño, J L Pablos, J J Gómez-Reino, C Conde
• Septic arthritis in Iceland 1990–2002: increasing incidence due to iatrogenic infections (27 September, 2007)

  Á J Geirsson, S Statkevicius, A Víkingsson
• The relationship of dyspnoea to function and quality of life in systemic sclerosis (29 August, 2007)

  M Baron, E Sutton, M Hudson, B Thombs, J Markland, J Pope, D Robinson, N Jones, P Docherty, M Abu-Hakima, S LeClercq, D Smith, J-P Mathieu
• The development of a preliminary ultrasonographic scoring system for features of hand osteoarthritis (17 August, 2007) Free

  H I Keen, F Lavie, R J Wakefield, M-A D’Agostino, H Berner Hammer, E Hensor, A Pendleton, D Kane, H Guerini, C Schueller-Weidekamm, M C Kortekaas, F Birrel, M Kloppenburg, T Stamm, I Watt, J S Smolen, E Maheu, M Dougados, P G Conaghan
• Factorial randomised controlled trial of glucocorticoids and combination disease modifying drugs in early rheumatoid arthritis (3 September, 2007)

  E H S Choy, C M Smith, V Farewell, D Walker, A Hassell, L Chau, D L Scott, for the CARDERA (Combination Anti-Rheumatic Drugs in Early Rheumatoid Arhritis) Trial Group
• Foxp3 expression in CD4⁺ T cells of patients with systemic lupus erythematosus: a comparative phenotypic analysis

  (29 August, 2007)

  M Bonelli, K von Dalwigk, A Savitskaya, J S Smolen, C Scheinecker
• Environmental risk factors for the development of psoriatic arthritis: results from a case–control study (6 September, 2007)

  E Pattison, B J Harrison, C E M Griffiths, A J Silman, I N Bruce
• Investigating the role of the HLA-Cw*06 and HLA-DRB1 genes in susceptibility to psoriatic arthritis: comparison with psoriasis and undifferentiated inflammatory arthritis

  (29 August, 2007)

  P Y P C Ho, A Barton, J Worthington, D Plant, C E M Griffiths, H S Young, P Bradburn, W Thomson, A J Silman, I N Bruce
• Correlation between bone lesion changes and cartilage volume loss in patients with osteoarthritis of the knee as assessed by quantitative magnetic resonance imaging over a 24-month period (29 August, 2007)

  J-P Raynauld, J Martel-Pelletier, M-J Berthiaume, F Abram, D Choquette, B Haraoui, J F Beary, G A Cline, J M Meyer, J-P Pelletier
• Prevalence of Sjögren syndrome among Nagasaki atomic bomb survivors (28 September, 2007)

  A Hida, M Akahoshi, Y Takagi, K Ashizawa, M Imaizumi, M Soda, R Maeda, E Nakashima, H Ida, A Kawakami, T Nakamura, K Eguchi
• Natural chondroitin sulphates increase aggregation of proteoglycan complexes and decrease adamts-5 expression in interleukin 1β-treated chondrocytes (27 September, 2007)

  K Tahiri, C Korwin-Zmijowska, P Richette, F Héraud, X Chevalier, J-F Savouret, M-T Corvol
• Development of a provisional core set of response measures for clinical trials of systemic sclerosis (24 September, 2007)

  D Khanna, D J Lovell, E Giannini, P J Clements, P A Merkel, J R Seibold, M Matucci-Cerinic, C P Denton, M D Mayes, V D Steen, J Varga, D E Furst, for the Scleroderma Clinical Trials Consortium co-authors